FindMyKOL
Clinical trialNCT00603304CompletedPhase 3Interventional

Complementary and Alternative Medicine for Urological Symptoms(CAMUS)

SponsorUniversity of Alabama at BirminghamEnrollment369Urological
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The CAMUS trial will test Saw palmetto in about 369 men. Men who decide to be part of the CAMUS trial will be given one out of two possible treatments at random. One out of every two men would get an inactive placebo treatment. One out of every two men would get Saw palmetto pills. This kind of scientific study is the best way to find out if the plant extracts really work to prevent men with benign prostatic hyperplasia (BPH) from getting worse. During the study, men will not know which of the two treatments they are assigned to. They will be followed very closely by a study team every 12 weeks to see how they are doing. Men in the CAMUS trial will be studied over 72 weeks. Tests and all medications needed as part of the study will be provided at no charge to the participant. Participants will be responsible for all other costs not associated with the study tests and medications. All information on study participants will be held in the strictest confidence and no one would have access to patient information other than the required authorized health care and research personnel.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Queen'S University

    Kingston, Ontario, Canada

United States
  • Kaiser Permanente Division of Research

    Oakland, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • Yale University

    New Haven, Connecticut, United States

  • Northwestern University

    Chicago, Illinois, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • Washington University

    St Louis, Missouri, United States

  • Cornell University

    New York, New York, United States

  • New York University

    New York, New York, United States

  • University of Texas - Southwestern Medical Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo - first 24 weeksPlacebo - weeks 24 - 48Placebo - weeks 48 - 72Saw Palmetto - first 24 weeksSaw Palmetto - weeks 24 - 48Saw Palmetto - weeks 48 - 72
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2008
Primary completion
31 Dec 2010
Completion
31 Dec 2010
Last update posted
12 Oct 2012
Registered enrollment
369
Registry id
NCT00603304
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.